POSTERISAN

This brand name is authorized in Poland

Active ingredients

The drug POSTERISAN contains one active pharmaceutical ingredient (API):

1 Escherichia coli (E. coli) UNII 514B9K0L10 - ESCHERICHIA COLI
Read about Escherichia coli (E. coli)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C05AX03	Other preparations, combinations	C Cardiovascular system → C05 Vasoprotectives → C05A Agents for treatment of hemorrhoids and anal fissures for topical use → C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use
Discover more medicines within C05AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100054553, 100054560

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.